
About Unix Biotech Limited
Data last updated:
Unix Biotech Limited is a public limited company based in Punjab, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 July 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232PB2001PLC024521.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5.55 Lakh. It was formerly known as Unix Biotech Private Limited. It is led by directors including Alok Kumar Gupta and Rakesh Behari Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B 9 Focal Pointderabassi Distt Patiala, Punjab, India.
The company has about 121 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unixbiotech.in.
Company details
CIN history
Unix Biotech has one previous CIN (Corporate Identification Number): L24232PB2001PLC024521. The current CIN is U24232PB2001PLC024521, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232PB2001PLC024521 | Current |
| L24232PB2001PLC024521 | Previous |
Contact details
Unix Biotech Limited's registered office is in Punjab. Its website is unixbiotech.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB 9 Focal Pointderabassi Distt Patiala, Punjab, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Unix Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Unix Biotech Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Unix Biotech Limited, buy the company report.
Board of directors of Unix Biotech Limited
Unix Biotech has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alok Kumar Gupta | Director | 15 Jul 2002 | 24 Years 4 Months | Current |
| Rakesh Behari Gupta | Director | 13 Jul 2001 | 25 Years 4 Months | Current |
| Asha Gupta Also directs: Udik Pharmaceuticals Private Limited | Director | 01 Oct 2004 | 22 Years 1 Months | Current |
Auditor
Unix Biotech Limited is audited by DKBS AND COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DKBS AND COMPANY | FY 2023 | 509398 |
Shareholding
The shareholding of Unix Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Unix Biotech Limited, buy the company report.
Legal cases
Unix Biotech Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Yavatmal, Maharashtra | Court case (Other Misc.Cri.Appln) | Filed against the company by an individual | Disposed |
To see the full case history of Unix Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unix Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Unix Biotech Limited has a workforce of 121 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 121 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Unix Biotech Limited, buy the company report.
GST
No GST registration is on our record for Unix Biotech Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Unix Biotech Limited has 3 board changes on record since 2001: 3 appointments. The latest: Asha Gupta was appointed as Director on 01 Oct 2004.
Frequently asked questions
Unix Biotech is an active public limited company based in Punjab, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 July 2001 (25+ years old) and is registered under CIN U24232PB2001PLC024521.
Unix Biotech has 3 current directors:
- Alok Kumar Gupta - Director
- Rakesh Behari Gupta - Director
- Asha Gupta - Director
The latest financial statements of Unix Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Unix Biotech is U24232PB2001PLC024521. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unix Biotech has 1 court case on record: 1 filed against it.
Unix Biotech was incorporated on 13 July 2001, making it 25+ years old. It is registered with the Registrar of Companies, Chandigarh.
Asha Gupta was appointed as Director on 01 Oct 2004. Alok Kumar Gupta was appointed as Director on 15 Jul 2002. Rakesh Behari Gupta was appointed as Director on 13 Jul 2001.
Unix Biotech can be reached through the website unixbiotech.in. Its registered office is in Punjab, India.
The registered office of Unix Biotech is at B 9 Focal Pointderabassi Distt Patiala, Punjab, India.
Unix Biotech operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

